FDA Adverse Event Injury Summary report: N

GRAFT PASSING WIRE

MDR report key: 5428112 · Received February 10, 2016

Report

Report Number
1220246-2016-00040
Event Type
Injury
Date Received
February 10, 2016
Date of Event
November 18, 2015
Report Date
January 19, 2016
Manufacturer
ARTHREX, INC.
Product Code
LXH
PMA / PMN Number
EXEMPT
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
RISK MANAGER

Narratives

Additional Manufacturer Narrative · 1

NO FURTHER PATIENT INFORMATION WAS PROVIDED AT THE TIME OF THIS REPORT OR MADE AVAILABLE IN RESPONSE TO FOLLOW-UP COMMUNICATION. NO ADDITIONAL ADVERSE CONSEQUENCES HAVE BEEN REPORTED FROM THIS EVENT. THIS DEVICE IS USED FOR TREATMENT. THE DEVICE WAS REQUESTED FOR EVALUATION BUT WAS NOT RETURNED, THEREFORE THE COMPLAINANT'S EVENT COULD NOT BE VERIFIED. THE CAUSE OF THE EVENT COULD NOT BE DETERMINED FROM THE INFORMATION AVAILABLE AND WITHOUT DEVICE EVALUATION. DEVICE HISTORY RECORD REVIEW REVEALED NOTHING RELEVANT TO THIS EVENT. THE MOST LIKELY CAUSE OF THIS TYPE OF EVENT IS DUE TO A TIGHT GRAFT DURING IMPLANT INSERTION. A TIGHT GRAFT CAN CAUSE THE IMPLANT AND GRAFT WIRE TO NOT BE PROPERLY ALIGNED PRIOR TO INSERTION OF THE TRANSFIX IMPLANT. SUCH OFF-ALIGNMENT PRIOR TO IMPLANT INSERTION MAY CAUSE THE WIRE TO BECOME PINCHED DURING INSERTION OF THE IMPLANT. IN ADDITION, REUSE OF THIS SINGLE-USE, DISPOSABLE GRAFT PASSING WIRE DEVICE MAY LEAD TO BREAKAGE AND RETAINED FRAGMENT(S). PER THE SURGICAL TECHNIQUE, TO FURTHER SIMPLIFY IMPLANT INSERTION, THE NITINOL WIRE IS SHIFTED MEDIALLY TO PLACE ANY WIRE KINKS MEDIAL TO THE FEMORAL TUNNEL. THE BIO-TRANSFIX DILATOR MAY BE INSERTED OVER THE WIRE TO CREATE A PILOT HOLE FOR THE IMPLANT AND TO FURTHER ENSURE PROPER GRAFT POSITIONING. THIS IS THE FIRST COMPLAINT OF THIS TYPE FOR THIS PART/LOT COMBINATION. THE POTENTIAL CAUSE(S) OF THIS EVENT WILL BE COMMUNICATED TO THE EVENT REPORTER. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A FOLLOW-UP REPORT WILL BE SUBMITTED. UNKNOWN DEVICE DISPOSITION.

Description of Event or Problem · 1

IT WAS REPORTED VIA AN FDA MEDWATCH REPORT THAT ON (B)(6) 2015, PATIENT HAD AN ACL PROCEDURE AND APPROXIMATELY TWO MONTHS POST-OP, THE PATIENT WAS BROUGHT BACK IN TO SURGERY TO REMOVE TWO PIECES OF RETAINED BROKEN GRAFT WIRE (FROM THE SET AR-1978S, LOT 1190881). FOLLOW-UP INVESTIGATION: THE PHYSICIANS AT THE FACILITY SWITCHED THEIR TECHNIQUE TO AN AM PORTAL APPROACH AND WERE USING THE AM PORTAL TRANS FIX GUIDES. THE WIRE THAT WAS BROKEN IS THE WIRE THAT IS USED TO PASS THE GRAFT THROUGH THE FEMORAL TUNNEL. ONCE THE GRAFT IS FIXATED INTO THE TUNNEL THE SURGEON INSERTS A TRANS FIX PIN OVER THE WIRE. ONCE THE PIN IS IMPLANTED THE WIRE IS SUPPOSED TO BE REMOVED. IN BOTH CASES THE WIRE WOULD NOT COME OUT. SO IT WAS BELIEVED THAT THE WIRE WAS PINCHED SOMEWHERE INSIDE OF THE IMPLANT AND WOULD NOT RELEASE. AFTER THE SURGEON TRIED TO PULL ON IT , THE WIRE EITHER BROKE OR WAS CUT FLUSH WITH THE IMPLANT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
85544 GRAFT PASSING WIRE ORTHOPEDIC MANUAL SURGICAL INSTRUMENT LXH ARTHREX, INC. 1190881

Patients

Seq Age Sex Outcome Treatment
1 Other